###### Summary box

What is already known about this subject?
=========================================

-   Sedation and therefore sedation-related risks can be avoided by use of nEGD. nEGD has the potential to reduce the consumable and pharmaceutical costs.

-   In Japan, nEGD is already performed on a regular basis, whereas in most countries in Europe it has not been implemented on a regular basis.

-   So far, high success rates of peroral gastroscopy as well as limited patient tolerance for unsedated gastroscopy are factors indicating the need for the implementation of nEGD in daily routine.

What are the new findings?
==========================

-   In this prospective clinical trial 84% of the participants were fairly up to extremely satisfied with the procedure received, independent of the method chosen.

-   Nasal pain decreased the odds of reselecting the method by more than 90% (OR=0.098, 95% CI 0.02 to 0.49, p\<0.005).

-   In this study, the proportion of outpatients who chose the nasal method (41%) was significantly different from zero (χ²=46 954.93, df=1, p\<0.001 with 95% CI 35% to 47%), which underlines an existing demand for nEGD in outpatients at the Department of Endoscopy at the University Hospital of Leipzig, Germany.

###### Summary box

How might it impact on clinical practice in the foreseeable future?
===================================================================

-   Transnasal gastroscopy (nEGD) with ultrathin endoscopes enhances feasibility and patient tolerance in unsedated patients without affecting the quality of the examination. This represents a substantial advance in the field of endoscopy.

-   In the present study, the demand for nEGD was evaluated as an alternative to diagnostic upper gastrointestinal endoscopy among outpatients referred to the university hospital. This study showed that patients will choose nEGD and thereby underlines the existence of a demand for nEGD in outpatients.

-   Guidelines for pretreatment and selection of patients for nEGD will have to be developed in order to facilitate the implementation of nEGD into the daily routine.

Introduction {#s1}
============

Numerous indications require upper gastrointestinal endoscopy (oesophagogastroduodenoscopy; EGD) regularly. As reviewed by Parker *et al*, conventional peroral EGD (oEGD) is used as the standard diagnostic method.[@R1] According to the guidelines of the German Society for Gastroenterology, Digestive and Metabolic Diseases, patients have the choice between an examination with or without sedation, using only local anaesthesia,[@R2] provided that no contraindications for sedation are known. Peroral gastroscopy under sedation (s-oEGD) increases patients' tolerance towards[@R3] and comfort[@R4] during the procedure. s-oEGD is also most common in Northern America[@R5] and is offered in many European countries as reviewed by Bell *et al.*[@R6] Sedation can increase anaesthesia-related risks, especially in patients presenting with a high American Society of Anesthesiologists score.[@R7] Adverse cardiopulmonary events are the most common risk.[@R6] Sedation requires close monitoring during and after the procedure which increases the procedure's total cost.[@R12]

Unsedated peroral gastroscopy (ns-oEGD) can increase patients' discomfort, which may reduce the overall quality of the examination.[@R15]

To further increase patients' comfort during the procedure, the use of ultrathin endoscopes was introduced. In the past, transnasal gastroscopy (nEGD) has been tested as an alternative to oEGD. Shaker reported the feasibility of unsedated nEGD in healthy volunteers in 1994.[@R17] In numerous publications, nEGD has been described as a promising alternative, as it reduces cardiac stress level,[@R18] shows good patient tolerance,[@R5] leads to less gagging,[@R18] and, at the same time, is effective and safe.[@R27] Further studies have shown a high rate of completed procedures as well as reselection of nEGD in patients, who experienced the unsedated method before.[@R16] According to a review on Japanese studies by Tatsumi *et al*, epistaxis is a main complication in nEGD (0%--5%).[@R30]

On the other hand, nEGD avoids sedation, which minimises the time required for postprocedure observation (cf Ustündag *et al*).[@R13] Also, according to a commentary by Bajaj and Shaker, it keeps the patient from losing a whole day at work[@R31] and has the potential to reduce the consumable and pharmaceutical costs by 65%--92%.[@R32] Additionally, nEGD is supposed to reduce pharyngeal discomfort and enables the patient to talk during the procedure.[@R18] nEGD is already performed on a regular basis in Asian countries, such as Japan, but in Europe it has been implemented as a regular procedure only in a few countries (eg, France).[@R13]

The objective of this study was to analyse the necessity and demand for nEGD as an alternative to oEGD in the daily routine in tertiary care and university hospitals.

Furthermore, we aimed to evaluate previous experiences with EGD and its effect on future choices of the patient for a certain examination method. Finally, the study examined the reasons for choosing nEGD or oEGD, evaluated the pain perceived during the procedure and surveyed the resulting preference for choosing a particular method in the future.

Materials and methods {#s2}
=====================

This prospective clinical study was conducted at the Department of Endoscopy at the University Hospital of Leipzig (UKL), Germany. All outpatients referred to diagnostic EGD at the department during the period from September 2016 until March 2017 were screened for inclusion. Inclusion criteria were: aged ≥18, signed informed consent to participate in this study as well as declaration of consent to undergo the procedure, and an adequate knowledge of oral and written German. Excluded were inpatients receiving EGD as well as all patients unfit to undergo ultrathin nEGD due to medical reasons. Medical reasons for exclusion were a narrow nasal cavity, the potential need to perform band ligation of oesophageal varices, abnormal coagulation profile, the placement of a percutaneous endoscopic gastrostomy, a planned colonoscopy under sedation on the same day or emergency procedures.

From 196 patients who were eligible to undergo nEGD, 194 chose a method. Data collection and evaluation was performed anonymously.

Procedure {#s2-1}
---------

Generally, all outpatients at UKL who will receive EGD are required to attend an informative meeting prior to their examination. Patients fulfilling the inclusion criteria for this study were then handed information explaining nEGD. Potential advantages (avoidance of sedation and the gag reflex as well as a shorter observational period following the procedure) and disadvantages (slightly prolonged procedure, danger of epistaxis and potential need to stop the procedure due to a narrow nasal cavity) were explained on this form. Additionally, the patients were asked to give further information on a questionnaire.

Offered methods were s-oEGD, ns-oEGD as well as unsedated nEGD.

In s-oEGD intravenous anaesthesia was performed with Propofol (Propofol 10 mg/mL Lipuro, B Braun Melsungen), which was administered under continuous monitoring of blood pressure, blood oxygen saturation, and ECG.

Local anaesthesia was used for patients undergoing ns-oEGD and nEGD. Patients with ns-oEGD received local throat anaesthesia with Xylocaine (Xylocaine 10 mg Spray, AstraZeneca). Patients undergoing nEGD were instructed to nasally inhale Lidocaine jelly (Instillagel 11 mL, Farco-Pharma).

All patients received EGD in the left lateral recumbent position.

Before 6 February 2017, nEGD was performed using solely the FUJIFILM-EG530N-Videoscope (Fujifilm, Tokyo, Japan) with an outer diameter of 5.9 mm and a working channel of 2 mm. After 6 February 2017, the FUJIFILM-EG-580NW2-Videoscope with an outer diameter of 5.9 mm and a working channel of 2.4 mm was used as well. ns-oEGD and s-oEGD were performed using the FUJIFILM-EG590WR-Video and FUJIFILM-EG530WR-Video endoscopes with an outer diameter of 9.3 mm and a working channel of 2.8 mm. All endoscopes had a length of 1100 mm.

A routine examination consisted of examining the upper gastrointestinal tract up to the descending part of the duodenum. Biopsy samplings were performed when needed.

Criteria for discontinuation of nEGD were impossible passage through the nasal cavity after trying both nostrils separately and severe epistaxis.

The endoscopies were performed by trained and experienced endoscopists.

Patients' questionnaire {#s2-2}
-----------------------

The questionnaire included on the first page information with descriptive imaging. This ensured standardised explanation of the procedure to minimise physicians' influence on the patients' decision-making for one or the other method.

The questionnaire itself consisted of two parts ([online supplementary file 1](#SP1){ref-type="supplementary-material"}). Part 1: Prior to the procedure the patients were asked to give information on their previous experience with EGD, their concerns regarding the actual examination, sociodemographic data, their choice of examination method (nEGD, ns-oEGD, s-oEGD) as well as their reasons for it.
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The second part was completed after the procedure, evaluating the discomfort experienced during the examination specifically during the procedure of intubation of the nose, discomfort felt in the throat or stomach, and severity of pain during the procedure. The discomfort was measured with the numeric analogue scale (NAS) (NAS 0: no discomfort; 10: pain could not be worse). Patients were also asked to state their future preference for following procedures and the reasons for their preference. Only patients who had chosen ns-oEGD or nEGD were asked to answer the second part of the questionnaire.

Physicians' questionnaire {#s2-3}
-------------------------

A questionnaire was handed out to the physicians performing the endoscopy exploring the endoscopic experience of the physician in general and with nEGD, their preference for a certain method, and if they wish to include nEGD in routine diagnostics ([online supplementary file 2](#SP2){ref-type="supplementary-material"}).
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Statistical analyses {#s2-4}
--------------------

For the statistical analysis, PASW statistics (SPSS. Released 2009. PASW Statistics for Windows. V.18.0. Chicago: SPSS) and R Core Team (2014) (R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL <http://www.R-project.org/>) were used. Descriptive statistics were used to determine the percentage of patients who chose nEGD, ns-oEGD or s-oEGD. Means were calculated and group variability was reported as the SD. Categorical data were compared by using Fisher's exact test or χ^2^ test. Data with a normal distribution were compared with a Student's t-test. Binary logistic regression was used to assess the effect of predictors for the repeated selection of nEGD. The dependent variable was repeated selection of the respective method (1=yes, 0=no). Independent variables in the model were satisfaction (1=moderate, fairly, and extremely; 0=little, not at all) and perceived nasal pain (1=yes; 0=no). Differences were considered statistically significant when p\<0.05. R function prop.test was used for testing the null that the proportions of individuals who reselected the same method for future examination is 0.5. Our sample size of 196 patients powers our analysis to estimate the proportion of patients who select a certain method with a two-sided 95% CI width equal to 11.7%, 13.2%, and 14.4% when the sample proportion would be 20%, 30%, and 50%, respectively.

This study was registered at ClinicalTrials.gov with the ID NCT03663491.

Results {#s3}
=======

Response rate {#s3-1}
-------------

During the study period a total of 2523 patients underwent EGD at UKL. Of this total number, 843 were enrolled as outpatients and were therefore potential candidates for this study. Of these, 283 (34%) agreed to participate in the study. Loss of candidates can be attributed to emergency examinations or patients who were referred to the department by special outpatient clinics that did not have access to the questionnaire needed for the study ([figure 1](#F1){ref-type="fig"}; [tables 1 and 2](#T1 T2){ref-type="table"}).

###### 

Overview of outpatients, University Clinic Leipzig, Gastroscopy (12 September 2016 to 17 March 2017)

  ------------------------------------- ---------------
  Total number of patients              2523
   Outpatients                          843 (33%)
   Inpatients                           1680 (67%)
  Outpatients                           843 (100%)
   Intravenous sedation                 327 (39%)
   Local anaesthesia                    429 (51%)
    Oral                                313/843 (37%)
    Nasal                               116/843 (14%)
   Without data\*                       83 (10%)
  Total number outpatients approached   283/843 (34%)
  ------------------------------------- ---------------

\*No reported choice for an examination method in the clinical records at the Department for Endoscopy at University Hospital Leipzig, Germany.

###### 

Number of patients approached and response rate categorised by the clinical feasibility of the transnasal approach

  Number of patients approached                          nEGD possible   nEGD not possible\*
  ------------------------------------------------------ --------------- ---------------------
  Method chosen                                                          
   Oral gastroscopy with intravenous sedation (s-oEGD)   45/194 (23%)    
   Oral gastroscopy with local anaesthesia (ns-oEGD)     33/194 (17%)    
   Nasal gastroscopy (nEGD)                              116/194 (60%)   

\*Exclusion criteria: narrow nasal cavity, potential need to perform band ligation of oesophageal varices, placement of a percutaneous endoscopic gastrostomy (PEG), emergency procedures.

![Flow chart. nEGD, transnasal gastroscopy; ns-oEGD, unsedated peroral gastroscopy; s-oEGD, peroral gastroscopy under sedation.](bmjgast-2018-000264f01){#F1}

General characteristics of the sample {#s3-2}
-------------------------------------

The group of participants medically eligible for nEGD consisted of 83 males (43%) and 110 females (57%), with an average age of 53 (±17) years (*[table 3](#T3){ref-type="table"}*).

###### 

Sociodemographic characteristics of the study population

  ------------------------------------------- ---------------
  Total sample, n=196 (100%)                  
  Age (mean±SD)                               53 (±17)
  Gender                                      
   Male                                       83/193 (43%)
   Female                                     110/193 (57%)
  Educational status                          
   Mandatory school                           39/174 (22%)
   High school                                81/174 (47%)
   University degree                          54/174 (31%)
  Reason for examination                      
   Monitoring                                 75/175 (43%)
   Symptoms                                   79/175 (45%)
   Preoperative                               21/175 (12%)
  Previous experience with oral gastroscopy   
   Yes                                        147/191 (77%)
   None                                       44/191 (23%)
  BMI (kg/m^2^)\*                             
   Underweight                                9/189 (5%)
   Healthy weight                             74/189 (39%)
   Overweight                                 42/189 (22%)
   Obesity                                    64/189 (34%)
  ------------------------------------------- ---------------

\*BMI (kg/m^2^): Age \<34 years: underweight (\<19 kg/m^2^), healthy weight (19--24 kg/m^2^), overweight (25--30 kg/m^2^), obesity (\>30 kg/m^2^). Age ≥34 years: underweight (\<19 kg/m^2^), healthy weight (19--26 kg/m^2^), overweight (27--30 kg/m^2^), obesity (\>30 kg/m^2^) (Deutsche Gesellschaft für Ernährung, The German Nutrition Society \[DGE\]).

BMI, body mass index.

Seventy-seven per cent (147/191) of the participants stated previous experience with EGD. Indications for EGD were general monitoring of Barrett's epithelium, oesophageal varices, ulcus, and so on (75/175, 43%), complaints and symptoms (79/175, 45%), and preinterventional examination before surgery or endoscopic suturing (21/175, 12%). There was no significant correlation between the indication for the examination and the examination method chosen (Fisher's exact test, p=0.347).

[Table 4](#T4){ref-type="table"} shows the sociodemographic data of the patients participating in the study. In contrast to age, the proportion of male and female patients differed significantly between the three groups (Fisher's exact test, p=0.013). No significant correlation between educational status (p=0.242), marital status (p=0.386) or body mass index (p=0.534) and the choice of a certain method could be shown. In all groups, the number of patients who stated previous experience with oEGD was higher than the number of those with no prior experience (147/44).

###### 

Examined study group categorised by type of examination method

  Method                                      s-oEGD        ns-oEGD       nEGD           P value
  ------------------------------------------- ------------- ------------- -------------- -----------------
  Age (mean±SD)                               48 (±16)       56 (±18)     53 (±16)       Not significant
  Gender                                                                                 
   Male                                       12/45 (27%)   12/33 (36%)   59/115 (51%)   0.013
   Female                                     33/45 (73%)   21/33 (64%)   56/115 (49%)   
  Educational status                                                                     
   Mandatory school                           13/44 (30%)   8/28 (29%)    18/105 (17%)   Not significant
   High school                                22/44 (50%)   11/28 (39%)   51/105 (49%)   
   University degree                          9/44 (20%)    9/28 (32%)    36/105 (34%)   
  BMI (kg/m^2^)\*                                                                        
   Underweight                                2/44 (5%)     2/33 (6%)     5/112 (4%)     
   Healthy weight                             22/44 (50%)   14/33 (42%)   38/112 (34%)   Not significant
   Overweight                                 9/44 (20%)    5/33 (15%)    28/112 (25%)   
   Obesity                                    11/44 (25%)   12/33 (37%)   41/112 (37%    
  Previous experience with oral gastroscopy                                              
   Yes                                        31/43 (72%)   28/33 (85%)   88/115 (77%)   Not significant
   None                                       12/43 (28%)   5/33 (15%)    27/115 (23%)   

\*BMI (kg/m^2^): Age \<34 years: underweight (\<19 kg/m^2^), healthy weight (19--24 kg/m^2^), overweight (25--30 kg/m^2^), obesity (\>30 kg/m^2^). Age ≥34 years: underweight (\<19 kg/m^2^), healthy weight (19--26 kg/m^2^), overweight (27--30 kg/m^2^), obesity (\>30 kg/m^2^) (Deutsche Gesellschaft für Ernährung, The German Nutrition Society \[DGE\]).

BMI, body mass index; nEGD, transnasal gastroscopy; ns-oEGD, unsedated peroral gastroscopy; s-oEGD, peroral gastroscopy under sedation.

The insertion failure rate for nEGD was 10%, all due to narrow nasal cavities. In these cases, the examination was then successfully finished with the ultrathin video endoscopes via the peroral route.

Perception of the chosen method {#s3-3}
-------------------------------

Eighty-four per cent of the participants were fairly up to extremely satisfied with their procedure, independent of the method chosen ([table 5](#T5){ref-type="table"}). Throughout the groups, a significant correlation between the degree of satisfaction and the re-election of the same procedure in future examination could be identified (Fisher's exact test, p=0.007).

###### 

Satisfaction rate characterised by chosen method

  nEGD (n=102)   ns-oEGD (n=27)                  
  -------------- ---------------- -------------- -------------
  Total sample   102 (100%)       Total sample   27 (100%)
   Not at all    4/102 (4%)        Not at all    0/27
   Little        2/102 (2%)        Little        0/27
   Moderate      11/102 (11%)      Moderate      3/27 (11%)
   Fairly        37/102 (36%)      Fairly        5/27 (19%)
   Extremely     48/102 (47%)      Extremely     19/27 (70%)

No significant difference in the rate of satisfaction (p=0.169).

nEGD, transnasal gastroscopy; ns-oEGD, unsedated peroral gastroscopy.

In the nEGD group, satisfaction with the endoscopy also correlated significantly with the re-election of the same method for future examination (Fisher's exact test, p=0.002). Due to the similarity of the OR (the ns-oEGD group \[4.7, 95% CI 0.06 to 142.5\] and the nEGD group \[5.5, 95% CI 1.3 to 22.8\]), the rate of satisfaction was not significantly different in the two groups (Fisher's exact test, nEGD: p=0.002; ns-oEGD: p=0.169).

The amount of perceived nasal pain (average 4.24 \[±2.36\]) had a significant impact on re-election of nEGD as the preferred method (p=0.001). Sex (p=0.59), throat pain (p=1.000), gag reflex (p=0.592) and abdominal pain (p=1.000) did not have a significant impact on the method re-elected.

Sex (p=0.25), throat pain perceived during the examination (p=1.000), the gag reflex (p=0.530), and abdominal pain (p=1.000) could not be identified as factors with significant impact on repeated selection in the ns-oEGD group.

To examine whether repeated selection was based on satisfaction or perceived nasal pain, a binary logistic regression was used to model the effect of these two factors in the 116 patients who had chosen nEGD. The full regression model (likelihood ratio test against intercept-only model: χ²=18 154, df=2, p\<0.001, n=99) as well as both variables can be considered significantly associated in repeated selection of the same method. The ORs of re-electing the same method were more than five times higher in satisfied patients in comparison to unsatisfied patients (OR=5.4, 95% CI 1.4 to 21.5, p=0.02). Nasal pain, however, decreased the odds of re-election of the same method by more than 90% (OR=0.098, 95% CI 0.02 to 0.49, p\<0.005). The *Nagelkerke* pseudo-R² of the model was 0.301, this corresponds with a strong impact according to Cohen.[@R34]

The proportion of outpatients with prior experience in oral gastroscopy who chose the nasal method and who would re-elect the nasal method for future examination was 84% (p=0.001 with 95% CI 73% to 91%).

There was also no significant difference between re-election rates within the three different methods (p=0.874, s-oEGD 16/18 \[89%\]; ns-oEGD 24/27 \[89%\]; nEGD 86/102 \[84%\]) ([tables 6--8](#T6 T7 T8){ref-type="table"}).

###### 

Study group (sample) categorised by selected method and repeated selection of the same method for potential future examination

  Chosen method                               ns-oEGD       nEGD
  ------------------------------------------- ------------- --------------
  Repeated selection for future examination                 
   Yes                                        24/27 (89%)   86/102 (84%)
   No                                         3/27 (11%)    16/102 (16%)

nEGD, transnasal gastroscopy; ns-oEGD, unsedated peroral gastroscopy.

###### 

Study group: selected method, repeated selection and previous experience of oral gastroscopy

  Experience                                  Yes           No                        
  ------------------------------------------- ------------- ------------- ----------- -------------
  Repeated selection for future examination                                           
   Yes                                        22/28 (79%)   66/88 (75%)   2/5 (40%)   20/27 (74%)
   No                                         2/28 (7%)     13/88 (15%)   1/5 (20%)   3/27 (11%)
   Incomplete data                            4/28 (14%)    9/88 (10%)    2/5 (40%)   4/27 (15%)

nEGD, transnasal gastroscopy; ns-oEGD, unsedated peroral gastroscopy.

###### 

Selected method and choice for future examination in the total sample group, n=147

  Chosen method        s-oEGD (n=18)   ns-oEGD (n=27)   nEGD (n=102)
  -------------------- --------------- ---------------- --------------
  Future examination                                    
   s-oEGD              16/18 (89%)     1/27 (4%)        10/102 (10%)
   ns-oEGD             1/18 (5.5%)     24/27 (89%)      6/102 (6%)
   nEGD                1/18 (5.5%)     2/27 (7%)        86/102 (84%)

Reselection rate 86% (p\<0.001).

nEGD, transnasal gastroscopy; ns-oEGD, unsedated peroral gastroscopy; s-oEGD, peroral gastroscopy under sedation.

Overall patient's re-election rate was 86% (126/147) which was significantly different from random choice (χ²=73.6, df=1, p\<0.001). This rate was similar among participants with prior EGD experience (101/116, 87%, χ²=62.3, df=1, p\<0.001) ([figure 2](#F2){ref-type="fig"}).

![Chosen method and preferred method for future examination.](bmjgast-2018-000264f02){#F2}

T-test showed no significant age difference (t=0259, df=125, p=0.796) nor Fisher's exact test a significant difference for sex (nEGD: p=0.59; ns-oEGD: p=0.25) in the groups that re-elected the same method for future proceedings.

The transnasal approach was chosen by 41% of patients included in this study (χ²=46 954.93, df=1, p\<0.001 with 95% CI 35% to 47%).

Physicians' responses concerning nEGD {#s3-4}
-------------------------------------

Ten physicians performed the endoscopies at the Department of Endoscopy at the UKL and answered the distributed questionnaire. Previous experience with standard endoscopic procedure was on average 7.6 years (±4.79). Six out of these 10 physicians expressed a desire to offer nEGD in daily practice. Reasoning was the avoidance of anaesthesia as well as faster mobilisation of the patients after completion of the examination. Two out of 10 stated nEGD as their preferred method of EGD, whereas six preferred ns-oEGD and two s-oEGD.

Discussion {#s4}
==========

EGD is frequently used as a diagnostic tool to detect gastrointestinal pathology. To reduce patients' discomfort and anxiety as well as to avoid sedation-related adverse effects, nEGD with ultrathin endoscopes has been considered a major advance in the field, enhancing feasibility and patient tolerance without affecting the quality of the examination.[@R19] A study conducted by Dumortier *et al* in France, including 1100 consecutive patients, in three different institutions, proved the feasibility of nEGD with ultrathin video endoscopes and showed patients' preference for this technique.[@R35] Further studies found nEGD to be safe, effective, and better tolerated by the patients.[@R27]

In the present study, we focused on the evaluation of a demand for nEGD as an alternative option for diagnostic EGD among outpatients referred to the UKL. In the group of outpatients who did not show medical conditions contradicting nEGD, 60% chose nEGD. This high proportion underlines an existing demand for nEGD in outpatients.

As reviewed by Tatsumi *et al*, nEGD is used increasingly for endoscopic procedures in Japan,[@R30] which poses the question why nEGD has not been implemented more frequently in other countries, for example, Germany.

One reason might be that up until now not many patients have undergone this procedure which makes a substantiated statement about the actual complication rates difficult as reviewed by Tatsumi *et al*.[@R30] Other reasons may be a lack of randomised prospective studies and cost-effectiveness analysis (cf Ustündag *et al*).[@R13] Further arguments questioning the need for the implementation of nEGD in daily practice are: the high success rate of oEGD,[@R36] a similar tolerance for oEGD compared with nEGD,[@R37] limited patient tolerance for unsedated gastroscopy, and a higher acceptability to undergo oEGD again if necessary, compared with nEGD.[@R38] In our study, nEGD failed in 10% of the examinations. oEGD was successfully performed with the ultrathin endoscope in all cases. Patients, who had chosen nEGD or ns-oEGD, were more likely to report the same procedure as their preference for future examinations; regardless of the method they were examined with. This indicates a similar tolerance towards both techniques. A preference for oEGD in general was not detected.

Neuenschwander *et al* stated nEGD as technically inferior to oEGD and that no benefit for overall comfort could have been found in the study including 98 patients (nEGD: 48; oEGD: 50). He stated though that the reduced stress levels during nEGD and its clinical relevance would have to be further investigated.[@R18] Furthermore, oEGD was found to be preferred by both physicians and patients in one study from 1999, using a 5.3 mm fibre-optic endoscope and a 5.9 mm video endoscope.[@R37] In 1999, ultrathin video endoscopes had not yet been implemented on a regular basis in endoscopic practice. When asked, 2 out of 10 practising physicians in our unit stated nEGD as their preferred method for diagnostic EGD, whereas six preferred ns-oEGD and two s-oEGD.

This may be explained by the lack of experience and training with nEGD as a daily routine causing doubts about advantages and qualities of nEGD.[@R29] Additionally, the expenses of buying the new technology might influence the implementation progress. The development of a dedicated nEGD training has been suggested to increase physicians' familiarity with the procedure (cf Parker *et al*).[@R1] A survey by Atar and Kadayifcienhanced the request for the inclusion of nEGD training in gastroenterology fellowships, as this method could reduce costs while maintaining the quality and increasing the patients' overall comfort, only nasal pain being a significant symptom during the examination.[@R40] Except for perceived nasal pain, nEGD was found to be better tolerated by EGD experienced patients in a randomised study by Kadayifci *et al*.[@R16] This overlaps with the findings of our present study, where, besides satisfaction, only perceived nasal pain had a significant impact on further patient choices for nEGD as the method for future examination. This could be moderated by sufficient nasal anaesthesia, which was found to be vital to reducing nasal pain during insertion.[@R36]

Concerns about the adequacy of biopsy samples taken with small forceps can be obliterated by studies that were able to prove the adequacy of small biopsy samples.[@R25] However, the overall adequacy of the biopsies will have to be further investigated in bigger studies. As limitations of the ultrathin endoscopes (which are used in nEGD) do not compromise diagnostic EGD, nEGD shows to be a great alternative for patients, in whom oEGD cannot be performed due to anatomical reasons.[@R43] Further studies testing the appropriateness of nEGD for interventional purposes need to be conducted. In the placement of feeding tubes, nEGD has shown to be an adequate alternative reducing procedure time and medication required,[@R44] even feasible in patients who are critically ill.[@R45] Success rates were found to be highly impacted by practice skills of the physicians.[@R45]

Epistaxis was, with 5%, found to be the most common complication during nEGD as reported in Japanese studies,[@R30] which generally stops spontaneously.[@R37] Other risks related to sedation, such as cardiopulmonary problems that might comprise up to 50% of complications and 60% of endoscopy-related deaths, according to Bell *et al*'s review,[@R6] can be avoided by nEGD practice. Additionally, Ooi and Thomson described endoscopist-directed nurse-administered propofol sedation as inappropriate for high-risk patients.[@R8] Following a prospective randomised comparative study, Yuki *et al* stated transnasal small-calibre endoscopy to even be a safer method compared with transoral conventional endoscopy in patients who are critical ill.[@R46]

Our study showed a demand for the offer of nEGD among outpatients. The overall satisfaction rate was high and 84% of the patients who had chosen nEGD were willing to undergo the same procedure in future examinations. Differing from previous studies,[@R35] no impact of age or sex on the decision for or re-election of a method was identified. This study is a single-centre study.

One limitation of the study is that potential outpatient candidates were missed due to organisational difficulties as well as difficulties in cooperation with specialised outpatient clinics that did not have access to the studies' questionnaire. Personal doubts among the physicians about the quality of the examination and, therefore, varying information given during the informative meeting may have had an impact on the total number of patients who did choose nEGD. The availability of the transnasal gastroscope with a working channel of 2.4 mm in our department from February 2017 onwards was an advantage as a previous retrospective study showed that this working channel size reduces suction and therefore overall procedure time significantly.[@R47] To further validate our findings of a potential demand for nEGD in the daily routine, larger studies will be needed, addressing the demand and the efficacy of pretreatment and increasing abilities of the responsible physician.

Following this study, at the Department of Endoscopy at the University Hospital Leipzig, Germany, nEGD is offered as an alternative for diagnostic endoscopy of the upper gastrointestinal tract in daily routine.

In conclusion, nEGD has proven to be a safe and well-tolerated alternative to oEGD. It has the potential to reduce sedation-related risks, reduce cost and enable EGD in patients not suitable for oEGD. nEGD therefore represents a substantial advance in the field of diagnostic endoscopy when being implemented in Germany. Regarding interventional EGD further studies will have to be conducted in order to be able to substantially make a statement about the amount of possible complications. Guidelines for pretreatment and the selection of patients for nEGD will have to be developed to facilitate the implementation of nEGD in daily routine.
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